Baxter buys Prism Pharmaceuticals for up to $338mm
- Payment Includes Cash
- Includes Earnout
- Acquisition of Private Biotech
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.